4//SEC Filing
VOLITIONRX LTD 4
Accession 0001078782-17-000451
$VNRXCIK 0000093314operating
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:11 PM ET
Size
5.4 KB
Accession
0001078782-17-000451
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Vanston David Cecil
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-04-10+100,000→ 100,000 totalExercise: $5.00From: 2018-04-10Exp: 2023-04-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]A total of 100,000 Options were granted on April 10, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000093314
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:11 PM ET
- Size
- 5.4 KB